Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Medicines register
Registers› Irish medicines ›Nicorette Freshfruit 4mg Medicated Chewing Gum
Medicines register · Ireland

Nicorette Freshfruit 4mg Medicated Chewing Gum

Authorisation PA23490/019/004 · JNTL Consumer Health (Ireland) Limited

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 19 Nov 2026
Licence holder
JNTL Consumer Health (Ireland) Limited (all products →)
Active substance
Nicotine
Clinical trials
3 clinical trials →
Dosage form
Medicated chewing-gum
Route of administration
Oral use
ATC codes
N07BA, N07BA01
First authorised
26/05/2006
Prescription status
Product not subject to medical prescription
Supply
Supply through non-pharmacy outlets and pharmacies
Legal basis
Not Currently Available

Nicotine: supply and approvals

48 authorised products on the HPRA list contain Nicotine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 19 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 19 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 19 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 20 years (since 26 May 2006). The HPRA list marks it as marketed in Ireland.

Other medicines with Nicotine in Ireland

47 other products on the HPRA list contain Nicotine, from 8 licence holders; 30 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
NiQuitin 14 mg/24 hrs transdermal patchesChefaro Ireland DAC,National authorisation (PA)Marketed
NiQuitin 21 mg/24 hrs transdermal patchesChefaro Ireland DAC,National authorisation (PA)Marketed
NiQuitin 7 mg/24 hrs transdermal patchesChefaro Ireland DAC,National authorisation (PA)Marketed
NiQuitin CLEAR 14 mg/24 hrs transdermal patchChefaro Ireland DAC,National authorisation (PA)Marketed
NiQuitin CLEAR 21 mg/24 hrs transdermal patchChefaro Ireland DAC,National authorisation (PA)Marketed
NiQuitin CLEAR 7 mg/24 hrs transdermal patchChefaro Ireland DAC,National authorisation (PA)Marketed
Nicorette 2mg Medicated Chewing-gumJNTL Consumer Health I (Ireland) LimitedNational authorisation (PA)Marketed
Nicorette 4mg Medicated Chewing-gumJNTL Consumer Health I (Ireland) LimitedNational authorisation (PA)Marketed
Nicorette Cools 2mg LozengeJNTL Consumer Health (Ireland) LimitedNational authorisation (PA)Marketed
Nicorette Cools 4mg LozengeJNTL Consumer Health (Ireland) LimitedNational authorisation (PA)Marketed
Nicorette Freshfruit 2mg Medicated Chewing GumJNTL Consumer Health (Ireland) LimitedNational authorisation (PA)Marketed
Nicorette Freshmint 2mg Medicated Chewing GumJNTL Consumer Health I (Ireland) LimitedNational authorisation (PA)Marketed

All 48 products with Nicotine →

Other substances in ATC group N07BA

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 5 other active substances share the group N07BA with this product:

Cytisinicline (2) · Varenicline tartrate (2) · Nicotine bitartrate dihydrate (2) · Cytisine (1) · Nicotine resinate (1)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

JNTL Consumer Health (Ireland) Limited holds 45 products on the HPRA list, with 20 different active substances; 41 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.